Growth Metrics

Pacific Biosciences Of California (PACB) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -45.82%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -45.82%
Dec 31, 2025 -41.92%
Sep 30, 2025 -42.97%
Jun 30, 2025 -43.90%
Mar 31, 2025 -48.51%
Dec 31, 2024 -50.65%
Jun 30, 2024 -39.96%
Mar 31, 2024 -56.52%
Dec 31, 2023 30.15%
Sep 30, 2023 77.44%
Jun 30, 2023 69.02%
Mar 31, 2023 72.56%
Dec 31, 2022 122.21%
Sep 30, 2022 109.55%
Jun 30, 2022 117.06%
Mar 31, 2022 123.86%
Dec 31, 2021 190.24%
Jun 30, 2021 171.17%
Mar 31, 2021 232.09%
Dec 31, 2020 70.36%
Sep 30, 2020 38.59%
Jun 30, 2020 5.92%
Mar 31, 2020 33.44%
Dec 31, 2019 20.90%
Sep 30, 2019 13.22%
Jun 30, 2019 7.00%
Mar 31, 2019 23.91%
Dec 31, 2018 -17.56%
Sep 30, 2018 11.84%
Jun 30, 2018 -3.84%
Mar 31, 2018 -5.61%
Dec 31, 2017 -23.21%
Sep 30, 2017 -9.86%
Jun 30, 2017 8.96%
Mar 31, 2017 -11.11%
Dec 31, 2016 -14.00%
Sep 30, 2016 -29.40%
Jun 30, 2016 -15.34%
Mar 31, 2016 -27.66%
Dec 31, 2015 -10.26%
Sep 30, 2015 -5.81%
Jun 30, 2015 -8.30%
Mar 31, 2015 -18.67%
Dec 31, 2014 -14.77%
Sep 30, 2014 -14.96%
Jun 30, 2014 -19.72%
Mar 31, 2014 -21.29%
Dec 31, 2013 -43.69%
Sep 30, 2013 1.08%
Jun 30, 2013 -23.20%